首页 > 最新文献

Communicable Diseases Intelligence最新文献

英文 中文
Invasive pneumococcal disease surveillance, 1 July to 30 September 2016. 2016年7月1日至9月30日侵袭性肺炎球菌病监测。
IF 1.6 Q4 INFECTIOUS DISEASES Pub Date : 2016-12-24 DOI: 10.33321/cdi.2016.40.69
Rachael Corvisy, Jennie Hood
{"title":"Invasive pneumococcal disease surveillance, 1 July to 30 September 2016.","authors":"Rachael Corvisy, Jennie Hood","doi":"10.33321/cdi.2016.40.69","DOIUrl":"https://doi.org/10.33321/cdi.2016.40.69","url":null,"abstract":"","PeriodicalId":51669,"journal":{"name":"Communicable Diseases Intelligence","volume":"40 4","pages":"E569-E573"},"PeriodicalIF":1.6,"publicationDate":"2016-12-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144276619","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Flutracking weekly online community survey of influenza-like illness annual report, 2015. 流感样疾病在线社区每周调查报告,2015年。
IF 1.6 Q4 INFECTIOUS DISEASES Pub Date : 2016-12-24 DOI: 10.33321/cdi.2016.40.58
Craig B Dalton, Sandra J Carlson, David N Durrheim, Michelle T Butler, Allen C Cheng, Heath A Kelly

Flutracking is a national online community influenza-like illness (ILI) surveillance system that monitors weekly ILI activity and impact in the Australian community. This article reports on the 2015 findings from Flutracking. From 2014 to 2015 there was a 38.5% increase in participants to 27,824 completing at least 1 survey with a peak weekly response of 25,071 participants. The 2015 Flutracking national ILI weekly fever and cough percentages peaked in late August at 5.0% in the unvaccinated group, in the same week as the national counts of laboratory confirmed influenza peaked. A similar percentage of Flutracking participants took two or more days off from work or normal duties in 2015 (peak level 2.3%) compared with 2014 (peak level 2.5%) and the peak weekly percentage of participants seeking health advice was 1.6% in both 2014 and 2015. Flutracking fever and cough peaked in the same week as Influenza Complications Alert Network surveillance system influenza hospital admissions. The percentage of Flutracking participants aged 5 to 19 years with cough and fever in 2015 was the highest since 2011. The 2015 season was marked by a transition to predominantly influenza B strain circulation, which particularly affected younger age groups. However, for those aged 20 years and over, the 2015 national Flutracking influenza season was similar to 2014 in community ILI levels and impact.

Flutracking是一个全国性的在线社区流感样疾病(ILI)监测系统,每周监测澳大利亚社区的流感样疾病活动及其影响。本文报告了Flutracking在2015年的研究结果。从2014年到2015年,完成至少一次调查的参与者增加了38.5%,达到27,824人,每周最多有25,071人参与。2015年流感追踪全国ILI每周发热和咳嗽百分比在8月下旬达到峰值,未接种疫苗组为5.0%,与实验室确认的全国流感计数达到峰值的同一周。与2014年(最高水平2.5%)相比,2015年Flutracking参与者休了两天或两天以上假(最高水平2.3%)的比例与2014年(最高水平2.5%)相似,2014年和2015年每周寻求健康建议的参与者比例最高为1.6%。在流感并发症警报网络监测系统流感入院的同一周内,流感追踪发烧和咳嗽达到高峰。2015年咳嗽和发烧的5至19岁Flutracking参与者的百分比是自2011年以来最高的。2015年流感季的特点是向以乙型流感毒株为主的流行过渡,尤其影响较年轻的年龄组。然而,对于20岁及以上的人群,2015年全国流感追踪季节在社区ILI水平和影响方面与2014年相似。
{"title":"Flutracking weekly online community survey of influenza-like illness annual report, 2015.","authors":"Craig B Dalton, Sandra J Carlson, David N Durrheim, Michelle T Butler, Allen C Cheng, Heath A Kelly","doi":"10.33321/cdi.2016.40.58","DOIUrl":"https://doi.org/10.33321/cdi.2016.40.58","url":null,"abstract":"<p><p>Flutracking is a national online community influenza-like illness (ILI) surveillance system that monitors weekly ILI activity and impact in the Australian community. This article reports on the 2015 findings from Flutracking. From 2014 to 2015 there was a 38.5% increase in participants to 27,824 completing at least 1 survey with a peak weekly response of 25,071 participants. The 2015 Flutracking national ILI weekly fever and cough percentages peaked in late August at 5.0% in the unvaccinated group, in the same week as the national counts of laboratory confirmed influenza peaked. A similar percentage of Flutracking participants took two or more days off from work or normal duties in 2015 (peak level 2.3%) compared with 2014 (peak level 2.5%) and the peak weekly percentage of participants seeking health advice was 1.6% in both 2014 and 2015. Flutracking fever and cough peaked in the same week as Influenza Complications Alert Network surveillance system influenza hospital admissions. The percentage of Flutracking participants aged 5 to 19 years with cough and fever in 2015 was the highest since 2011. The 2015 season was marked by a transition to predominantly influenza B strain circulation, which particularly affected younger age groups. However, for those aged 20 years and over, the 2015 national Flutracking influenza season was similar to 2014 in community ILI levels and impact.</p>","PeriodicalId":51669,"journal":{"name":"Communicable Diseases Intelligence","volume":"40 4","pages":"E512-E520"},"PeriodicalIF":1.6,"publicationDate":"2016-12-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144276616","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Australian vaccine preventable disease epidemiological review series: Influenza 2006 to 2015. 澳大利亚疫苗可预防疾病流行病学综述系列:2006 - 2015年流感。
IF 1.6 Q4 INFECTIOUS DISEASES Pub Date : 2016-12-24 DOI: 10.33321/cdi.2016.40.54
Jean Li-Kim-Moy, Jiehui Kevin Yin, Cyra Patel, Frank H Beard, Clayton Chiu, Kristine K Macartney, Peter B McIntyre

Introduction: Influenza is a major contributor to the preventable health burden of Australians each year. The National Immunisation Program provides influenza vaccine for those at highest risk of severe disease. This review of influenza epidemiology examines current data on influenza disease burden in Australia, in the context of several comparable countries having programs with much broader eligibility for influenza vaccine in children.

Methods: Influenza notifications (2006-2015), hospitalisations, and deaths (2006-2013) were sourced and age-specific rates calculated. Comparisons were made across age groups in the pre-pandemic, pandemic, and post-pandemic periods and by Indigenous and non-Indigenous status.

Results: The 2009 pandemic year and the 2012 non-pandemic season resulted in the highest rates of notification, hospitalisation and death. Influenza notification rates were 4.0 times higher and hospitalisation rates 2.1 times higher during 2011-2013 compared with 2006-2008. Death rates varied widely, but peaks corresponded to high-activity seasons. Influenza hospitalisation rates were highest among those aged <5 and ≥65 years, but influenza-attributable deaths were identified primarily in those aged ≥75 years. Significantly higher notification and hospitalisation rates were seen for all Indigenous people, but higher death rates were largely restricted to the 2009 pandemic year.

Conclusions: Based on notifications, hospitalisations and deaths, burden of disease from influenza is highest at the extremes of life and is significantly higher among Indigenous people of all ages. This pattern of disease burden warrants consideration of widened eligibility for influenza vaccine under the National Immunisation Program to all Indigenous people and all children less than 5 years of age.

简介:流感是澳大利亚人每年可预防的健康负担的主要原因。国家免疫规划为患严重疾病风险最高的人提供流感疫苗。本流感流行病学综述审查了澳大利亚流感疾病负担的当前数据,并与几个具有更广泛儿童流感疫苗接种资格的国家进行了比较。方法:收集流感通报(2006-2015年)、住院和死亡(2006-2013年)数据,并计算特定年龄的比率。对大流行前、大流行和大流行后各年龄组以及土著和非土著身份进行了比较。结果:2009年大流行年和2012年非大流行季节的报告率、住院率和死亡率最高。与2006-2008年相比,2011-2013年流感通报率高出4.0倍,住院率高出2.1倍。死亡率差异很大,但高峰与高活动季节相对应。结论:根据通报、住院和死亡情况,流感造成的疾病负担在生命的极端阶段最高,在所有年龄段的土著人民中都要高得多。这种疾病负担模式值得考虑在国家免疫方案下扩大流感疫苗接种资格,使所有土著人和所有5岁以下儿童都能接种流感疫苗。
{"title":"Australian vaccine preventable disease epidemiological review series: Influenza 2006 to 2015.","authors":"Jean Li-Kim-Moy, Jiehui Kevin Yin, Cyra Patel, Frank H Beard, Clayton Chiu, Kristine K Macartney, Peter B McIntyre","doi":"10.33321/cdi.2016.40.54","DOIUrl":"https://doi.org/10.33321/cdi.2016.40.54","url":null,"abstract":"<p><strong>Introduction: </strong>Influenza is a major contributor to the preventable health burden of Australians each year. The National Immunisation Program provides influenza vaccine for those at highest risk of severe disease. This review of influenza epidemiology examines current data on influenza disease burden in Australia, in the context of several comparable countries having programs with much broader eligibility for influenza vaccine in children.</p><p><strong>Methods: </strong>Influenza notifications (2006-2015), hospitalisations, and deaths (2006-2013) were sourced and age-specific rates calculated. Comparisons were made across age groups in the pre-pandemic, pandemic, and post-pandemic periods and by Indigenous and non-Indigenous status.</p><p><strong>Results: </strong>The 2009 pandemic year and the 2012 non-pandemic season resulted in the highest rates of notification, hospitalisation and death. Influenza notification rates were 4.0 times higher and hospitalisation rates 2.1 times higher during 2011-2013 compared with 2006-2008. Death rates varied widely, but peaks corresponded to high-activity seasons. Influenza hospitalisation rates were highest among those aged <5 and ≥65 years, but influenza-attributable deaths were identified primarily in those aged ≥75 years. Significantly higher notification and hospitalisation rates were seen for all Indigenous people, but higher death rates were largely restricted to the 2009 pandemic year.</p><p><strong>Conclusions: </strong>Based on notifications, hospitalisations and deaths, burden of disease from influenza is highest at the extremes of life and is significantly higher among Indigenous people of all ages. This pattern of disease burden warrants consideration of widened eligibility for influenza vaccine under the National Immunisation Program to all Indigenous people and all children less than 5 years of age.</p>","PeriodicalId":51669,"journal":{"name":"Communicable Diseases Intelligence","volume":"40 4","pages":"E482-E495"},"PeriodicalIF":1.6,"publicationDate":"2016-12-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144276614","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Australian Gonococcal Surveillance Programme, 1 January to 31 March 2016. 澳大利亚淋球菌监测计划,2016年1月1日至3月31日。
IF 1.6 Q4 INFECTIOUS DISEASES Pub Date : 2016-12-24 DOI: 10.33321/cdi.2016.40.64
Monica M Lahra, Rodney P Enriquez
{"title":"Australian Gonococcal Surveillance Programme, 1 January to 31 March 2016.","authors":"Monica M Lahra, Rodney P Enriquez","doi":"10.33321/cdi.2016.40.64","DOIUrl":"https://doi.org/10.33321/cdi.2016.40.64","url":null,"abstract":"","PeriodicalId":51669,"journal":{"name":"Communicable Diseases Intelligence","volume":"40 4","pages":"E554-E556"},"PeriodicalIF":1.6,"publicationDate":"2016-12-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144276609","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
National Notifiable Diseases Surveillance System, 1 July to 30 September 2016. 国家法定传染病监测系统,2016年7月1日至9月30日。
IF 1.6 Q4 INFECTIOUS DISEASES Pub Date : 2016-12-24 DOI: 10.33321/cdi.2016.40.62
{"title":"National Notifiable Diseases Surveillance System, 1 July to 30 September 2016.","authors":"","doi":"10.33321/cdi.2016.40.62","DOIUrl":"https://doi.org/10.33321/cdi.2016.40.62","url":null,"abstract":"","PeriodicalId":51669,"journal":{"name":"Communicable Diseases Intelligence","volume":"40 4","pages":"E545-E551"},"PeriodicalIF":1.6,"publicationDate":"2016-12-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144276620","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
OzFoodNet quarterly report, 1 July to 30 September 2014. OzFoodNet季度报告,2014年7月1日至9月30日。
IF 1.6 Q4 INFECTIOUS DISEASES Pub Date : 2016-12-24 DOI: 10.33321/cdi.2016.40.61
{"title":"OzFoodNet quarterly report, 1 July to 30 September 2014.","authors":"","doi":"10.33321/cdi.2016.40.61","DOIUrl":"https://doi.org/10.33321/cdi.2016.40.61","url":null,"abstract":"","PeriodicalId":51669,"journal":{"name":"Communicable Diseases Intelligence","volume":"40 4","pages":"E539-E544"},"PeriodicalIF":1.6,"publicationDate":"2016-12-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144276621","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Haycocknema perplexum: an emerging cause of parasitic myositis in Australia. 困惑Haycocknema:在澳大利亚寄生虫性肌炎的新原因。
IF 1.6 Q4 INFECTIOUS DISEASES Pub Date : 2016-12-24 DOI: 10.33321/cdi.2016.40.55
Luke J Vos, Thomas Robertson, Enzo Binotto

Haycocknema perplexum is a rare cause of parasitic myositis, with all cases of human infection reported from Australia. This case involved an 80-year-old Queensland wildlife carer, who presented with muscle weakness, mild eosinophilia and creatine kinase elevation. This case supports an association with native animal contact and highlights the debilitating nature of this infection.

困惑菌是一种罕见的寄生虫性肌炎的病因,所有的人类感染病例都来自澳大利亚。该病例涉及一名80岁的昆士兰野生动物护理人员,他表现为肌肉无力,轻度嗜酸性粒细胞增多和肌酸激酶升高。该病例支持了与本地动物接触的关联,并突出了这种感染的衰弱性。
{"title":"Haycocknema perplexum: an emerging cause of parasitic myositis in Australia.","authors":"Luke J Vos, Thomas Robertson, Enzo Binotto","doi":"10.33321/cdi.2016.40.55","DOIUrl":"https://doi.org/10.33321/cdi.2016.40.55","url":null,"abstract":"<p><p>Haycocknema perplexum is a rare cause of parasitic myositis, with all cases of human infection reported from Australia. This case involved an 80-year-old Queensland wildlife carer, who presented with muscle weakness, mild eosinophilia and creatine kinase elevation. This case supports an association with native animal contact and highlights the debilitating nature of this infection.</p>","PeriodicalId":51669,"journal":{"name":"Communicable Diseases Intelligence","volume":"40 4","pages":"E496-E499"},"PeriodicalIF":1.6,"publicationDate":"2016-12-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144276617","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Australian Gonococcal Surveillance Programme, 1 April to 30 June 2016. 澳大利亚淋球菌监测规划,2016年4月1日至6月30日。
IF 1.6 Q4 INFECTIOUS DISEASES Pub Date : 2016-12-24 DOI: 10.33321/cdi.2016.40.65
Monica M Lahra, Rodney P Enriquez
{"title":"Australian Gonococcal Surveillance Programme, 1 April to 30 June 2016.","authors":"Monica M Lahra, Rodney P Enriquez","doi":"10.33321/cdi.2016.40.65","DOIUrl":"https://doi.org/10.33321/cdi.2016.40.65","url":null,"abstract":"","PeriodicalId":51669,"journal":{"name":"Communicable Diseases Intelligence","volume":"40 4","pages":"E557-E559"},"PeriodicalIF":1.6,"publicationDate":"2016-12-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144276608","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rise in invasive serogroup W meningococcal disease in Australia 2013-2015. 2013-2015年澳大利亚浸润性血清W群脑膜炎球菌病发病率上升
IF 1.6 Q4 INFECTIOUS DISEASES Pub Date : 2016-12-24 DOI: 10.33321/cdi.2016.40.49
Mark Gk Veitch, Rhonda L Owen
{"title":"Rise in invasive serogroup W meningococcal disease in Australia 2013-2015.","authors":"Mark Gk Veitch, Rhonda L Owen","doi":"10.33321/cdi.2016.40.49","DOIUrl":"https://doi.org/10.33321/cdi.2016.40.49","url":null,"abstract":"","PeriodicalId":51669,"journal":{"name":"Communicable Diseases Intelligence","volume":"40 4","pages":"E451-E453"},"PeriodicalIF":1.6,"publicationDate":"2016-12-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144276623","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Australian Meningococcal Surveillance Programme, 1 April to 30 June 2016. 澳大利亚脑膜炎球菌监测规划,2016年4月1日至6月30日。
IF 1.6 Q4 INFECTIOUS DISEASES Pub Date : 2016-09-30 DOI: 10.33321/cdi.2016.40.47
Monica M Lahra, Rodnay P Enriquez
{"title":"Australian Meningococcal Surveillance Programme, 1 April to 30 June 2016.","authors":"Monica M Lahra, Rodnay P Enriquez","doi":"10.33321/cdi.2016.40.47","DOIUrl":"10.33321/cdi.2016.40.47","url":null,"abstract":"","PeriodicalId":51669,"journal":{"name":"Communicable Diseases Intelligence","volume":"40 3","pages":"E447"},"PeriodicalIF":1.6,"publicationDate":"2016-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9365103","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Communicable Diseases Intelligence
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1